Memory Pharmaceuticals' Seed - III Round

Memory Pharmaceuticals raised a round of funding on October 01, 1998.

Memory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bip…

Articles about Memory Pharmaceuticals' Seed - III Round: